Skip to main content
Top

Expert commentary: DEPICT-1 and inTandem3

print
PRINT
insite
SEARCH

Parth Narendran discusses the findings of two trials testing SGLT2 inhibitors in patients with type 1 diabetes (5:47).
Read the accompanying news stories on the DEPICT-1 and inTandem3 results

print
PRINT

More on this topic

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »